Exactech Inc. (EXAC)
NASDAQ: EXAC
· Real-Time Price · USD
49.25
0.00 (0.00%)
At close: Jun 29, 2019, 12:07 AM
Exactech Revenue Breakdown
| Period Ending | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|
| Biologics and Spine Segment Revenue | 19.5M | 84.42M | 23.83M | 25.49M | 24.46M |
| Biologics and Spine Segment Revenue Growth | -76.89% | +254.31% | -6.51% | +4.18% | n/a |
| Corporate Segment Revenue | n/a | 42.66M | 79M | 65.53M | 52.06M |
| Corporate Segment Revenue Growth | -100.00% | -46.01% | +20.56% | +25.87% | n/a |
| Extremities Segment Revenue | 100.33M | 70.86M | 43.49M | 40.96M | 40.83M |
| Extremities Segment Revenue Growth | +41.57% | +62.94% | +6.18% | +0.32% | n/a |
| Hip Segment Revenue | 46.75M | 21.28M | 78.68M | 80.53M | 81.39M |
| Hip Segment Revenue Growth | +119.67% | -72.95% | -2.30% | -1.05% | n/a |
| Knee Segment Revenue | 76.19M | n/a | 23.38M | 24.58M | 25.6M |
| Knee Segment Revenue Growth | n/a | n/a | -4.92% | -3.97% | n/a |
| Other Segment Revenue | 14.81M | n/a | n/a | n/a | n/a |
| Other Segment Revenue Growth | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|
| Domestic Revenue | 176.77M | 168.14M | 165.57M | 159.65M |
| Domestic Revenue Growth | +5.13% | +1.55% | +3.71% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 28.62M | 29.19M | 31.59M | 29.06M | 26.87M | 29.48M | 29.23M | 28.87M | 25.77M | 27.24M | 27.7M |
| Selling, General, and Administrative Revenue Growth | -1.95% | -7.59% | +8.72% | +8.14% | -8.84% | +0.83% | +1.24% | +12.06% | -5.41% | -1.65% | n/a |
| Research and Development Revenue | 5.73M | 5.38M | 6.22M | 5.88M | 5.1M | 5.33M | 5.07M | 5M | 5.26M | 4.6M | 4.53M |
| Research and Development Revenue Growth | +6.49% | -13.56% | +5.81% | +15.42% | -4.37% | +5.11% | +1.50% | -5.00% | +14.25% | +1.61% | n/a |
| Sales and Marketing Revenue | 22.71M | 23.57M | 25.05M | 23.61M | 21.68M | 23.84M | 23.32M | 23.19M | 20.59M | 21.46M | 21.85M |
| Sales and Marketing Revenue Growth | -3.63% | -5.92% | +6.09% | +8.90% | -9.02% | +2.21% | +0.54% | +12.66% | -4.09% | -1.77% | n/a |